Soru

Zorluk: ZorNormal Pregnancy and Prenatal Care

A 2828-year-old woman, gravida 22, para 11, presents to the clinic for her initial prenatal evaluation at 99 weeks gestation based on her last menstrual period. Her only complaints are mild fatigue and intermittent morning nausea, which improve with small meals. She has no significant past medical history and takes a daily prenatal vitamin. Her vital signs are within normal limits. Physical examination reveals a normal-appearing thyroid gland with no palpable enlargement or nodules. Pelvic examination is consistent with her gestational age. Because of her fatigue, a primary care physician previously ordered laboratory tests prior to this obstetric visit. The results are as follows:

Thyroid-stimulating hormone (TSH): 0.10.1 μ\mu U/mL (Reference: 0.50.5–5.05.0 μ\mu U/mL)
Total thyroxine (Total T4): 14.214.2 μ\mu g/dL (Reference: 5.05.0–12.012.0 μ\mu g/dL)
Free thyroxine (Free T4): 1.41.4 ng/dL (Reference: 0.80.8–2.02.0 ng/dL)

Which of the following is the most appropriate next step in the management of this patient?

  1. Reassurance and continuation of routine prenatal careCevap
  2. B
    Measurement of thyroid-stimulating immunoglobulin
  3. C
    Initiation of propylthiouracil therapy
  4. D
    Initiation of levothyroxine therapy
  5. E
    Radioactive iodine uptake scan

Cevap

The most appropriate next step is reassurance and continuation of routine prenatal care, as the patient's laboratory findings represent normal physiologic adaptations to early pregnancy.
The correct response is reassurance and continuation of routine prenatal care. In a normal pregnancy, two primary hormonal changes alter thyroid function tests. First, human chorionic gonadotropin (beta-hCG) shares a common alpha subunit with TSH and weakly stimulates the maternal TSH receptor. This leads to slightly increased free thyroid hormone production and a subsequent negative feedback suppression of TSH, which is most pronounced at the end of the first trimester when beta-hCG peaks. Second, increased circulating estrogen stimulates the hepatic synthesis of thyroxine-binding globulin (TBG) and decreases its clearance. This increase in TBG binds more thyroid hormone in the serum, resulting in a significantly elevated Total T4. However, the biologically active fraction, Free T4, remains within the normal reference range (or high-normal). Because this patient's Free T4 is normal and her symptoms (mild fatigue, nausea) are typical of early pregnancy, she is clinically euthyroid. No further evaluation or pharmacological treatment is indicated.

Adım Adım Çözüm

1
Analyze the patient's thyroid laboratory results in the context of her symptoms.
The patient has a decreased TSH, an elevated Total T4, and a normal Free T4. She lacks symptoms of true hyperthyroidism.
Determining whether these lab values represent true pathology or expected pregnancy changes is the critical diagnostic branching point.
2
Evaluate the physiological effects of pregnancy on the thyroid axis.
High beta-hCG levels in the first trimester directly stimulate the TSH receptor, causing a transient decrease in TSH. Simultaneously, increased estrogen stimulates hepatic production of thyroxine-binding globulin (TBG), which elevates Total T4 levels without altering the biologically active Free T4.
Understanding the distinct hormonal mechanisms of beta-hCG and estrogen confirms that this lab profile is normal for a 9-week gestation.
3
Determine the appropriate clinical intervention.
Because the Free T4 is normal and the patient is clinically euthyroid, no pharmacological intervention or further specialized testing is indicated.
Treating normal physiological changes can cause significant harm to both the mother and the developing fetus.

Anahtar Kavram

During the first trimester of a normal pregnancy, beta-hCG stimulates the TSH receptor (decreasing TSH) and estrogen increases thyroxine-binding globulin (increasing Total T4). Free T4 remains in the normal range, indicating clinical euthyroidism.
Bu soruyu puanla